Ignite Creation Date:
2025-12-24 @ 3:58 PM
Ignite Modification Date:
2025-12-24 @ 3:58 PM
Study NCT ID:
NCT04123392
Status:
UNKNOWN
Last Update Posted:
2019-10-10
First Post:
2019-10-09
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TP53+ Myeloid tumors
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None